Pharmacological reduction of lipid hydroperoxides as a potential modulator of sarcopenia
Jacob L. Brown(Oklahoma Medical Research Foundation), Holly Van Remmen(Oklahoma Medical Research Foundation)
Cited by 5
Related Papers
The histone deacetylase inhibitor butyrate improves metabolism and reduces muscle atrophy during aging
|Aging Cell|2015|321
Protein imbalance in the development of skeletal muscle wasting in tumour‐bearing mice
|Journal of Cachexia Sarcopenia and Muscle|2018|112
Muscle mitochondrial catalase expression prevents neuromuscular junction disruption, atrophy, and weakness in a mouse model of accelerated sarcopenia
|Journal of Cachexia Sarcopenia and Muscle|2021|79
Elevated phospholipid hydroperoxide glutathione peroxidase (GPX4) expression modulates oxylipin formation and inhibits age-related skeletal muscle atrophy and weakness
|Redox Biology|2023|52
Modulation of sarcopenia phenotypes by glutathione peroxidase 4 overexpression in mice
|The Journal of Physiology|2023|17